Skip to content
Learning that drives better investment decisions

Shenzhen Salubris Pharmaceuticals – World Class Benchmarking

Company: Shenzhen Salubris Pharmaceuticals Company Limited

Bloomberg ticker: 002294 SZ

Market cap: US$5,091m

Background: Shenzhen Salubris Pharmaceuticals Company Limited produces pharmaceutical and healthcare products like tablets, capsules, injection formulations, and active pharmaceutical ingredients.

World Class Benchmarking of Shenzhen Salubris Pharmaceuticals



 

  • Profitable Growth rank of 8 was down compared to the prior period’s 6th rank
  • This is below average performance compared to 420 medium Health Care companies worldwide
  • Profitability rank of 8 was better than its Growth rank of 9
  • Profitability rank of 8 was down compared to the prior period’s 6th rank
  • This is below average performance compared to peers
  • Growth rank of 9 was the same compared to the prior period’s 9th rank
  • This is poor performance compared to peers

 


DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.